BRAF and thyroid gland carcinoma: Based on this study, point mutations were identified in 30-83% of specific thyroid cancer types, and among PTC, the genetic profiles of follicular variant PTC are dominated by RAS mutation while the BRAF is the major mutation in CPTC.